CORONA Remedies Limited has clarified that the recent movement in the volume of its shares is purely market-driven.

The company confirmed it is fully compliant with all disclosure obligations and currently has no undisclosed or price-sensitive information, impending announcements, or corporate actions that require sharing with the exchange.

For retail investors, this means the recent trading activity stems from market forces rather than any internal corporate developments, ensuring transparency regarding the company's current business status.